Fluorouracil-based Chemoradiation with Either Gemcitabine or Fluorouracil Chemotherapy after Resection of Pancreatic Adenocarcinoma: 5-Year Analysis of the U.S. Intergroup/RTOG 9704 Phase III Trial
Top Cited Papers
Open Access
- 10 March 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Annals of Surgical Oncology
- Vol. 18 (5), 1319-1326
- https://doi.org/10.1245/s10434-011-1630-6
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Analysis of Fluorouracil-Based Adjuvant Chemotherapy and Radiation After Pancreaticoduodenectomy for Ductal Adenocarcinoma of the Pancreas: Results of a Large, Prospectively Collected Database at the Johns Hopkins HospitalJournal of Clinical Oncology, 2008
- Adjuvant Radiotherapy and Chemotherapy for Pancreatic Carcinoma: The Mayo Clinic Experience (1975-2005)Journal of Clinical Oncology, 2008
- A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic CancerThe New England Journal of Medicine, 2004
- Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: Postoperative Adjuvant Chemoradiation Improves SurvivalAnnals of Surgery, 1997
- Long-Term Survival After Resection for Ductal Adenocarcinoma of the Pancreas Is It Really Improving?Annals of Surgery, 1995
- Patterns of failure after curative resection of pancreatic carcinomaCancer, 1990
- Pancreatic CancerArchives of Surgery, 1985
- Pancreatic and periampullary carcinoma: Experience with 200 patients over a 12 year periodThe American Journal of Surgery, 1982
- The randomization and stratification of patients to clinical trialsJournal of Chronic Diseases, 1974
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958